Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Cue Biopharma, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 90 | 89 | −1 |
| Shares | 18.6M | 16.9M | −1.69M (−9.1%) |
| Value | $216.4M | $245.6M | +$29.2M (+13.5%) |
New holders (5)
Institutions that held Cue Biopharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 27,189 | $396.0K | 0.00% |
| Invesco Ltd. | 12,763 | $186.0K | 0.00% |
| SG Americas Securities, LLC | 10,912 | $159.0K | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 200 | $2.00K | 0.00% |
| Signaturefd, LLC | 85 | $1.00K | 0.00% |
Sold out (6)
Institutions that held Cue Biopharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Voss Capital, LLC | 125,000 | $1.46M |
| Rock Creek Group, LP | 35,714 | $416.0K |
| Trexquant Investment LP | 34,935 | $407.0K |
| Virtu Financial LLC | 24,887 | $290.0K |
| Citadel Advisors LLC | 21,755 | $253.0K |
| Parallax Volatility Advisers, L.P. | 16,724 | $195.0K |